Universe Pharmaceuticals (UPC) Receivables Refunds (2023 - 2024)
Historic Receivables Refunds for Universe Pharmaceuticals (UPC) over the last 3 years, with Q3 2025 value amounting to $1.0 billion.
- Universe Pharmaceuticals' Receivables Refunds rose 11523.61% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 11523.61%. This contributed to the annual value of $1.0 billion for FY2025, which is 11523.61% up from last year.
- According to the latest figures from Q3 2025, Universe Pharmaceuticals' Receivables Refunds is $1.0 billion, which was up 11523.61% from $475.3 million recorded in Q3 2024.
- In the past 5 years, Universe Pharmaceuticals' Receivables Refunds registered a high of $1.0 billion during Q3 2025, and its lowest value of $478899.0 during Q3 2023.
- Moreover, its 3-year median value for Receivables Refunds was $475.3 million (2024), whereas its average is $499.6 million.
- Its Receivables Refunds has fluctuated over the past 5 years, first soared by 9915495.77% in 2024, then soared by 11523.61% in 2025.
- Over the past 3 years, Universe Pharmaceuticals' Receivables Refunds (Quarter) stood at $478899.0 in 2023, then skyrocketed by 99154.96% to $475.3 million in 2024, then skyrocketed by 115.24% to $1.0 billion in 2025.
- Its Receivables Refunds was $1.0 billion in Q3 2025, compared to $475.3 million in Q3 2024 and $478899.0 in Q3 2023.